Dedicated to the treatment of metabolic, fibrotic and inflammatory diseases using our drug discovery platform and data-driven approach

About us

We are a development-stage biopharmaceutical company focused on developing distinctive novel small molecule therapeutics for metabolic, fibrotic and inflammatory diseases using our drug discovery platform and data-driven approach.

Read More

Product pipeline

Our expertise in small molecules has enabled a strong pipeline with potential first/best-in-class drug candidates.

Read More
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.